Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
A macular degeneration and peroxide technology, applied in the direction of active ingredients of peroxide compounds, medical preparations of non-active ingredients, medical preparations containing active ingredients, etc., can solve problems such as danger
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0073] Example 1: Ozonolysis of Unsaturated Hydrocarbons
[0074] The ozonolysis of olefins is carried out in solvent or neat. In both cases, cooling of the reaction mixture is critical in avoiding explosive decomposition of the peroxidic product of the reaction.
[0075] The following general procedure is typical for the ozonolysis of liquid olefins.
[0076] A 1 liter flask equipped with a magnetic stirrer was charged with olefin (2 moles) and the apparatus was weighed. The flask was placed in a cooling bath (ice-water or ice-salt). When the contents have cooled below 5°C, agitation is started and dry oxygen containing ozone (typically 3% ozone) is passed through the mixture. It is convenient to vent the ozone-containing oxygen through the glass frit, but this is not necessary for a solution that is being stirred. Gas flow is periodically interrupted for reaction vial weighing or reaction mixture sampling, after which gas flow is resumed.
[0077] When the weight of the...
Embodiment 2
[0080] Embodiment 2: the preparation of pharmaceutical preparation
[0081] The preferred pharmaceutical formulation of the present invention is prepared as follows:
[0082] (1) Ozone / pure oxygen gas mixture 120mg / L is bubbled through dienol, 3,7-dimethyl-2,6-octadien-1-ol (geraniol), 1 liter / hour;
[0083] (2) The reaction temperature is maintained at about 5°C;
[0084] (3) A small portion of the reaction product is taken out every 1 hour and passed through H 1 NMR to detect the formation of peroxides or reaction products;
[0085] (4) When there are more than 50% available unsaturated bond reactions, stop the reaction;
[0086] (5) Dilute the product mixture (1:10) with dimethyl sulfoxide to form a solution or dispersion;
[0087] (6) Before being applied to the target biological system, add a sufficient amount of dry powder mixture of hematoporphyrin, rose bengal and menaquinone to the solution or dispersion, and spread it in the target biological system when injected...
Embodiment 3
[0088] Embodiment 3: the example of pharmaceutical preparation
[0089] Two preferred formulations are as follows:
[0090] a.
[0091] weight%
[0092] *Detected by mass spectrometry
[0093] b.
[0094] weight%
[0095] *Detected by mass spectrometry
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com